205 related articles for article (PubMed ID: 27690252)
1. Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical/interventional treatments.
House PM; Stodieck SR
Clin Neurol Neurosurg; 2016 Nov; 150():181-184. PubMed ID: 27690252
[TBL] [Abstract][Full Text] [Related]
2. Octreotide: a therapeutic option for idiopathic intracranial hypertension.
Panagopoulos GN; Deftereos SN; Tagaris GA; Gryllia M; Kounadi T; Karamani O; Panagiotidis D; Koutiola-Pappa E; Karageorgiou CE; Piadites G
Neurol Neurophysiol Neurosci; 2007 Jul; ():1. PubMed ID: 17700925
[TBL] [Abstract][Full Text] [Related]
3. Venous sinus stenting for idiopathic intracranial hypertension: a review of the literature.
Puffer RC; Mustafa W; Lanzino G
J Neurointerv Surg; 2013 Sep; 5(5):483-6. PubMed ID: 22863980
[TBL] [Abstract][Full Text] [Related]
4. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature.
Giridharan N; Patel SK; Ojugbeli A; Nouri A; Shirani P; Grossman AW; Cheng J; Zuccarello M; Prestigiacomo CJ
Neurosurg Focus; 2018 Jul; 45(1):E10. PubMed ID: 29961379
[TBL] [Abstract][Full Text] [Related]
5. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic intracranial hypertension VISION (venous intervention versus shunting in IIH for optic nerve disc swelling) trial: patient perspective questionnaire.
Chandran A; Pulhorn H; McMahon C
Br J Neurosurg; 2019 Feb; 33(1):71-75. PubMed ID: 28934871
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
Aguilar-Pérez M; Henkes H
Ophthalmologe; 2015 Oct; 112(10):821-7. PubMed ID: 26400795
[TBL] [Abstract][Full Text] [Related]
9. [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].
Willenborg KD; Nacimiento W
Ophthalmologe; 2015 Oct; 112(10):814-20. PubMed ID: 26377103
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
Noda M; Sonoda Y; Takemoto M; Kira R
No To Hattatsu; 2017 May; 49(3):207-10. PubMed ID: 30113799
[TBL] [Abstract][Full Text] [Related]
11. Medical and surgical management of idiopathic intracranial hypertension in pregnancy.
Tang RA; Dorotheo EU; Schiffman JS; Bahrani HM
Curr Neurol Neurosci Rep; 2004 Sep; 4(5):398-409. PubMed ID: 15324607
[TBL] [Abstract][Full Text] [Related]
12. Predictors of admission and shunt revision during emergency department visits for shunt-treated adult patients with idiopathic intracranial hypertension.
Sankey EW; Elder BD; Liu A; Carson KA; Goodwin CR; Jusué-Torres I; Rigamonti D
J Neurosurg; 2017 Aug; 127(2):233-239. PubMed ID: 27662535
[TBL] [Abstract][Full Text] [Related]
13. Frameless stereotactic ventricular shunt placement for idiopathic intracranial hypertension.
Woodworth GF; McGirt MJ; Elfert P; Sciubba DM; Rigamonti D
Stereotact Funct Neurosurg; 2005; 83(1):12-6. PubMed ID: 15724109
[TBL] [Abstract][Full Text] [Related]
14. Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension.
Spitze A; Lam P; Al-Zubidi N; Yalamanchili S; Lee AG
Indian J Ophthalmol; 2014 Oct; 62(10):1015-21. PubMed ID: 25449938
[TBL] [Abstract][Full Text] [Related]
15. Fulminant Idiopathic Intracranial Hypertension.
Bouffard MA
Curr Neurol Neurosci Rep; 2020 Mar; 20(4):8. PubMed ID: 32219578
[TBL] [Abstract][Full Text] [Related]
16. Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
Wilkes BN; Siatkowski RM
J Neuroophthalmol; 2009 Dec; 29(4):281-3. PubMed ID: 19952899
[TBL] [Abstract][Full Text] [Related]
17. High-pressure headaches: idiopathic intracranial hypertension and its mimics.
Peng KP; Fuh JL; Wang SJ
Nat Rev Neurol; 2012 Dec; 8(12):700-10. PubMed ID: 23165338
[TBL] [Abstract][Full Text] [Related]
18. Shunt freedom and clinical resolution of idiopathic intracranial hypertension after bariatric surgery in the pediatric population: report of 3 cases.
Hoang KB; Hooten KG; Muh CR
J Neurosurg Pediatr; 2017 Dec; 20(6):511-516. PubMed ID: 28960170
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.
Tarrats L; Hernández G; Busquets JM; Portela JC; Serrano LA; González-Sepúlveda L; Sánchez-Pérez JR
Int Forum Allergy Rhinol; 2017 Jun; 7(6):615-623. PubMed ID: 28383199
[TBL] [Abstract][Full Text] [Related]
20. Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment.
Besch D; Makowski C; Steinborn MM; Bonfig W; Sadowski B
Neuropediatrics; 2013 Aug; 44(4):203-7. PubMed ID: 23275258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
